These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23274410

  • 21. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32869841
    [Abstract] [Full Text] [Related]

  • 22. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.
    Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, Lv J, Song Z, Li Y, Ji L, Pan S, Jiang H, Sun B.
    Biochem Pharmacol; 2014 Apr 01; 88(3):322-33. PubMed ID: 24522113
    [Abstract] [Full Text] [Related]

  • 23. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 01; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 24. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):236-46. PubMed ID: 25499970
    [Abstract] [Full Text] [Related]

  • 25. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
    Song L, Chen X, Mi L, Liu C, Zhu S, Yang T, Luo X, Zhang Q, Lu H, Liang X.
    Cancer Sci; 2020 Nov 15; 111(11):4242-4256. PubMed ID: 32926492
    [Abstract] [Full Text] [Related]

  • 26. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ.
    Int J Oncol; 2011 Nov 15; 39(5):1123-31. PubMed ID: 21743963
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug 15; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 28. Baicalin induces apoptosis of gallbladder carcinoma cells in vitro via a mitochondrial-mediated pathway and suppresses tumor growth in vivo.
    Shu YJ, Bao RF, Wu XS, Weng H, Ding Q, Cao Y, Li ML, Mu JS, Wu WG, Ding QC, Liu TY, Jiang L, Hu YP, Tan ZJ, Wang P, Liu YB.
    Anticancer Agents Med Chem; 2014 Aug 15; 14(8):1136-45. PubMed ID: 24568162
    [Abstract] [Full Text] [Related]

  • 29. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway.
    Liang C, Li H, Shen C, Lai J, Shi Z, Liu B, Tao HM.
    Anticancer Agents Med Chem; 2012 Jun 15; 12(5):554-63. PubMed ID: 22263786
    [Abstract] [Full Text] [Related]

  • 30. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
    Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH.
    J Cell Biochem; 2010 May 15; 110(1):171-81. PubMed ID: 20213764
    [Abstract] [Full Text] [Related]

  • 31. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
    Mol Cancer; 2011 Aug 16; 10():98. PubMed ID: 21843371
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W, Hu Z, Huang Y, Zheng H, Sun Q, Yang Q, Zhang Y, Zhang L, Wang W.
    Biomed Res Int; 2019 Aug 16; 2019():9205851. PubMed ID: 31019975
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Osthole inhibits the progression of human gallbladder cancer cells through JAK/STAT3 signal pathway both in vitro and in vivo.
    Le Zou T, Wang HF, Ren T, Shao ZY, Yuan RY, Gao Y, Zhang YJ, Wang XA, Liu YB.
    Anticancer Drugs; 2019 Nov 16; 30(10):1022-1030. PubMed ID: 31283543
    [Abstract] [Full Text] [Related]

  • 40. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb 16; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.